Archive photo of WHO headquarters in Geneva, Switzerland (Reuters)
Geneva:
The World Health Organization is reviewing interim data from its large multi-country trial of the combination of anti-HIV drugs Lopinavir and Ritonavir to treat COVID-19 patients, the chief scientist of the United Nations agency said on Thursday. , Soumya Swaminathan.
The comments come after WHO on Wednesday stopped testing the hydroxychloroquine malaria drug in the trial of treatments for COVID-19 patients, after studies have shown it shows no benefit in those with disease. She said more study is needed to see if hydroxchloroquine can prevent infection.
(This story has not been edited by GalacticGaming staff and is automatically generated from a syndicated feed.)
